329 related articles for article (PubMed ID: 2809596)
1. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method.
Ozaki N; Nakahara D; Miura H; Kasahara Y; Nagatsu T
J Neurochem; 1989 Dec; 53(6):1861-4. PubMed ID: 2809596
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum.
Tanganelli S; von Euler G; Fuxe K; Agnati LF; Ungerstedt U
Brain Res; 1989 Nov; 502(2):319-24. PubMed ID: 2819469
[TBL] [Abstract][Full Text] [Related]
3. Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis.
Zetterström T; Ungerstedt U
Eur J Pharmacol; 1984 Jan; 97(1-2):29-36. PubMed ID: 6199219
[TBL] [Abstract][Full Text] [Related]
4. The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on spontaneous release.
Andersen SL; Gazzara RA
J Neurochem; 1993 Dec; 61(6):2247-55. PubMed ID: 8245975
[TBL] [Abstract][Full Text] [Related]
5. Effects of halothane anaesthesia on extracellular levels of dopamine, dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindolacetic acid in rat striatum: a microdialysis study.
Ståhle L; Collin AK; Ungerstedt U
Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):136-40. PubMed ID: 1700307
[TBL] [Abstract][Full Text] [Related]
6. Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors.
Tanganelli S; Fuxe K; von Euler G; Agnati LF; Ferraro L; Ungerstedt U
Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):300-4. PubMed ID: 2280797
[TBL] [Abstract][Full Text] [Related]
7. Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites.
Kito S; Shimoyama M; Arakawa R
Jpn J Pharmacol; 1986 Jan; 40(1):57-67. PubMed ID: 2870204
[TBL] [Abstract][Full Text] [Related]
8. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
Bacopoulos NG; Roth RH
Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
[TBL] [Abstract][Full Text] [Related]
9. The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis.
Chai B; Meltzer HY
Neurosci Lett; 1992 Jun; 140(1):47-50. PubMed ID: 1383891
[TBL] [Abstract][Full Text] [Related]
10. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
Nomura Y; Komori T; Okuda S; Segawa T
Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
[TBL] [Abstract][Full Text] [Related]
11. Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis.
Tanganelli S; Fuxe K; von Euler G; Eneroth P; Agnati LF; Ungerstedt U
J Neural Transm Gen Sect; 1990; 81(3):183-94. PubMed ID: 2397084
[TBL] [Abstract][Full Text] [Related]
12. Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenylacetic acid and homovanillic acid in conscious and anesthetized rats.
Chapman CD; Gazzara RA; Howard SG
Neuropharmacology; 1990 Apr; 29(4):319-25. PubMed ID: 2342635
[TBL] [Abstract][Full Text] [Related]
13. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
Walters DE; Howard SG
Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
[TBL] [Abstract][Full Text] [Related]
14. Phenylalanine administration influences dopamine release in the rat's corpus striatum.
During MJ; Acworth IN; Wurtman RJ
Neurosci Lett; 1988 Oct; 93(1):91-5. PubMed ID: 3211373
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine-induced dopamine release in the medial frontal cortex of freely moving rats.
Kashihara K; Hamamura T; Okumura K; Otsuki S
Jpn J Psychiatry Neurol; 1991 Sep; 45(3):677-80. PubMed ID: 1800816
[TBL] [Abstract][Full Text] [Related]
16. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
17. The release of endogenous dopamine and its metabolites from rat striatum as detected in push-pull perfusates: effects of systematically administered drugs.
Radhakishun FS; Korf J; Venema K; Westerink BH
Pharm Weekbl Sci; 1983 Aug; 5(4):153-8. PubMed ID: 6622209
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
Invernizzi R; Morali F; Pozzi L; Samanin R
Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
[TBL] [Abstract][Full Text] [Related]
19. Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites.
Phebus LA; Clemens JA
Life Sci; 1989; 44(19):1335-42. PubMed ID: 2469926
[TBL] [Abstract][Full Text] [Related]
20. A kinetic study of the rate of formation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brain of the rat: implications for the origin of DOPAC.
Soares-da-Silva P; Garrett MC
Neuropharmacology; 1990 Oct; 29(10):869-74. PubMed ID: 1979427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
